The European Patent Office granted and published patent EP3340874A1 for an impedance measurement system developed by Impedimed Limited. The patent application includes inventors Jack Gerald Cosentino, Tim Essex, and Matthew Joseph Miller. IPC classifications indicate the technology covers bioelectrical impedance measurement (A61B 5/0537), general diagnostic measurement (A61B 5/00), physiological monitoring (A61B 5/0245, A61B 5/08), and healthcare data processing (G16H 40/67). The patent is designated for all 32 European contracting states.

Patent publications are informational notices requiring no immediate compliance action. Competitors developing similar bioelectrical impedance measurement technology should review this patent to assess potential freedom-to-operate implications and identify areas of non-overlap. Companies operating in the medical device or digital health sectors should evaluate whether their products or research activities may fall within the scope of this granted patent claims.